Use of IgG in oral fluid to monitor infants with suspected congenital toxoplasmosis

Emmanuelle Chapey, Valeria Meroni, François Kieffer, Lina Bollani, René Ecochard, Patricia Garcia, Martine Wallon, François Peyron

Research output: Contribution to journalArticle

Abstract

Infants born to mothers who seroconverted for toxoplasmosis during pregnancy are at risk of sequelae. In the case of a negative work-up at birth, congenital infection can be ruled out only by monitoring the disappearance of maternal immunoglobulin G (IgG) transmitted through the placenta, which can be achieved by regular blood sampling during the first year. To alleviate the discomfort of this follow-up, we developed an indirect enzyme-linked immunosorbent assay to detect specific IgG diffusing passively from the blood through the gingival epithelium by collecting oral fluid on microsponges. To assess the feasibility of the test, 212 patients were first enrolled. Levels of specific IgG in oral fluid were significantly higher in seropositive (n=195) than in seronegative (n=17) patients (mean optical densities, 1.145 ± 0.99 versus 0.092 ± 0.127; P <0.0001). In a population of 93 patients<15 months of age born to mothers who displayed toxoplasmic infection during pregnancy, 70 were free of congenital infection and were followed up until their serology turned negative, and 23 were congenitally infected. The same patterns of IgG were observed in the oral fluid and sera in each group. Using a cutoff of 0.04 (optical density value), the sensitivity and specificity of the test were 67.9% and 80.3%, respectively, and the probability of not having a congenital infection when the test on oral fluid was negative was 99%. Although the performance of the test needs to be improved, oral fluid sampling appears to be a promising tool for monitoring infants with suspected congenital toxoplasmosis.

Original languageEnglish
Pages (from-to)398-403
Number of pages6
JournalClinical and Vaccine Immunology
Volume22
Issue number4
DOIs
Publication statusPublished - Apr 1 2015

Fingerprint

Congenital Toxoplasmosis
Immunoglobulin G
Fluids
Mothers
Infection
Density (optical)
Blood
Pregnancy
Toxoplasmosis
Sampling
Serology
Immunosorbents
Placenta
Monitoring
Epithelium
Enzyme-Linked Immunosorbent Assay
Parturition
Assays
Sensitivity and Specificity
Serum

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology
  • Immunology and Allergy
  • Microbiology (medical)

Cite this

Use of IgG in oral fluid to monitor infants with suspected congenital toxoplasmosis. / Chapey, Emmanuelle; Meroni, Valeria; Kieffer, François; Bollani, Lina; Ecochard, René; Garcia, Patricia; Wallon, Martine; Peyron, François.

In: Clinical and Vaccine Immunology, Vol. 22, No. 4, 01.04.2015, p. 398-403.

Research output: Contribution to journalArticle

Chapey, Emmanuelle ; Meroni, Valeria ; Kieffer, François ; Bollani, Lina ; Ecochard, René ; Garcia, Patricia ; Wallon, Martine ; Peyron, François. / Use of IgG in oral fluid to monitor infants with suspected congenital toxoplasmosis. In: Clinical and Vaccine Immunology. 2015 ; Vol. 22, No. 4. pp. 398-403.
@article{01994cfb274e42f1b47b177bfd3e2249,
title = "Use of IgG in oral fluid to monitor infants with suspected congenital toxoplasmosis",
abstract = "Infants born to mothers who seroconverted for toxoplasmosis during pregnancy are at risk of sequelae. In the case of a negative work-up at birth, congenital infection can be ruled out only by monitoring the disappearance of maternal immunoglobulin G (IgG) transmitted through the placenta, which can be achieved by regular blood sampling during the first year. To alleviate the discomfort of this follow-up, we developed an indirect enzyme-linked immunosorbent assay to detect specific IgG diffusing passively from the blood through the gingival epithelium by collecting oral fluid on microsponges. To assess the feasibility of the test, 212 patients were first enrolled. Levels of specific IgG in oral fluid were significantly higher in seropositive (n=195) than in seronegative (n=17) patients (mean optical densities, 1.145 ± 0.99 versus 0.092 ± 0.127; P <0.0001). In a population of 93 patients<15 months of age born to mothers who displayed toxoplasmic infection during pregnancy, 70 were free of congenital infection and were followed up until their serology turned negative, and 23 were congenitally infected. The same patterns of IgG were observed in the oral fluid and sera in each group. Using a cutoff of 0.04 (optical density value), the sensitivity and specificity of the test were 67.9{\%} and 80.3{\%}, respectively, and the probability of not having a congenital infection when the test on oral fluid was negative was 99{\%}. Although the performance of the test needs to be improved, oral fluid sampling appears to be a promising tool for monitoring infants with suspected congenital toxoplasmosis.",
author = "Emmanuelle Chapey and Valeria Meroni and Fran{\cc}ois Kieffer and Lina Bollani and Ren{\'e} Ecochard and Patricia Garcia and Martine Wallon and Fran{\cc}ois Peyron",
year = "2015",
month = "4",
day = "1",
doi = "10.1128/CVI.00552-14",
language = "English",
volume = "22",
pages = "398--403",
journal = "Clinical and Vaccine Immunology",
issn = "1556-6811",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Use of IgG in oral fluid to monitor infants with suspected congenital toxoplasmosis

AU - Chapey, Emmanuelle

AU - Meroni, Valeria

AU - Kieffer, François

AU - Bollani, Lina

AU - Ecochard, René

AU - Garcia, Patricia

AU - Wallon, Martine

AU - Peyron, François

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Infants born to mothers who seroconverted for toxoplasmosis during pregnancy are at risk of sequelae. In the case of a negative work-up at birth, congenital infection can be ruled out only by monitoring the disappearance of maternal immunoglobulin G (IgG) transmitted through the placenta, which can be achieved by regular blood sampling during the first year. To alleviate the discomfort of this follow-up, we developed an indirect enzyme-linked immunosorbent assay to detect specific IgG diffusing passively from the blood through the gingival epithelium by collecting oral fluid on microsponges. To assess the feasibility of the test, 212 patients were first enrolled. Levels of specific IgG in oral fluid were significantly higher in seropositive (n=195) than in seronegative (n=17) patients (mean optical densities, 1.145 ± 0.99 versus 0.092 ± 0.127; P <0.0001). In a population of 93 patients<15 months of age born to mothers who displayed toxoplasmic infection during pregnancy, 70 were free of congenital infection and were followed up until their serology turned negative, and 23 were congenitally infected. The same patterns of IgG were observed in the oral fluid and sera in each group. Using a cutoff of 0.04 (optical density value), the sensitivity and specificity of the test were 67.9% and 80.3%, respectively, and the probability of not having a congenital infection when the test on oral fluid was negative was 99%. Although the performance of the test needs to be improved, oral fluid sampling appears to be a promising tool for monitoring infants with suspected congenital toxoplasmosis.

AB - Infants born to mothers who seroconverted for toxoplasmosis during pregnancy are at risk of sequelae. In the case of a negative work-up at birth, congenital infection can be ruled out only by monitoring the disappearance of maternal immunoglobulin G (IgG) transmitted through the placenta, which can be achieved by regular blood sampling during the first year. To alleviate the discomfort of this follow-up, we developed an indirect enzyme-linked immunosorbent assay to detect specific IgG diffusing passively from the blood through the gingival epithelium by collecting oral fluid on microsponges. To assess the feasibility of the test, 212 patients were first enrolled. Levels of specific IgG in oral fluid were significantly higher in seropositive (n=195) than in seronegative (n=17) patients (mean optical densities, 1.145 ± 0.99 versus 0.092 ± 0.127; P <0.0001). In a population of 93 patients<15 months of age born to mothers who displayed toxoplasmic infection during pregnancy, 70 were free of congenital infection and were followed up until their serology turned negative, and 23 were congenitally infected. The same patterns of IgG were observed in the oral fluid and sera in each group. Using a cutoff of 0.04 (optical density value), the sensitivity and specificity of the test were 67.9% and 80.3%, respectively, and the probability of not having a congenital infection when the test on oral fluid was negative was 99%. Although the performance of the test needs to be improved, oral fluid sampling appears to be a promising tool for monitoring infants with suspected congenital toxoplasmosis.

UR - http://www.scopus.com/inward/record.url?scp=84925456814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925456814&partnerID=8YFLogxK

U2 - 10.1128/CVI.00552-14

DO - 10.1128/CVI.00552-14

M3 - Article

C2 - 25651923

AN - SCOPUS:84925456814

VL - 22

SP - 398

EP - 403

JO - Clinical and Vaccine Immunology

JF - Clinical and Vaccine Immunology

SN - 1556-6811

IS - 4

ER -